**Core Concept**
Small cell carcinoma of the lung is a highly aggressive neuroendocrine tumor that often produces ectopic hormones, leading to systemic symptoms such as Cushing's syndrome, SIADH, and hypercalcemia. The increased hormone levels are due to the tumor's ability to express and secrete various hormones, including ACTH, ADH, and calcitonin.

**Why the Correct Answer is Right**
Small cell carcinoma of the lung is known to produce and secrete various hormones, leading to systemic symptoms. The increased hormone levels are due to the tumor's ability to express and secrete various hormones, including ACTH, ADH, and calcitonin. The production of these hormones is a result of the tumor's neuroendocrine differentiation.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as small cell carcinoma of the lung is not typically associated with increased parathyroid hormone-related protein (PTHrP) levels. Instead, it's more commonly associated with hypercalcemia due to the production of calcitonin.

**Option B:** This option is incorrect as small cell carcinoma of the lung is not typically associated with increased insulin levels. Instead, it's more commonly associated with hypoglycemia due to the production of insulin-like growth factor-1 (IGF-1) or insulin-like growth factor-2 (IGF-2).

**Option C:** This option is incorrect as small cell carcinoma of the lung is not typically associated with increased gastrin levels. Instead, it's more commonly associated with Zollinger-Ellison syndrome due to the production of gastrin-releasing peptide (GRP).

**Clinical Pearl / High-Yield Fact**
Small cell carcinoma of the lung is a highly aggressive tumor that can produce ectopic hormones, leading to systemic symptoms. It's essential to consider this diagnosis in patients with unexplained endocrine symptoms, particularly those with a history of smoking.

**Correct Answer: D.**